Arcturus Therapeutics Holdings Inc. (ARCT)

ARCT Revenue

In the year 2023, Arcturus Therapeutics Holdings had annual revenue of $166.80M, a decrease of -19.03%. Revenue in the quarter ending December 31, 2023 was $30.86M, a -80.75% decrease year-over-year.

• Revenue (ttm): $166.80M
• Revenue Growth: -19.03%
• P/S Ratio: 4.28
• Revenue / Employee: $926,661
• Employees: 180
• Market Cap: 713.79M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	166.80M	-39.20M	-19.03%
Dec 31, 2022	206.00M	193.64M	1,566.79%
Dec 31, 2021	12.36M	2.82M	29.56%
Dec 31, 2020	9.54M	-11.25M	-54.12%
Dec 31, 2019	20.79M	5.04M	31.97%
Dec 31, 2018	15.75M	2.76M	21.20%
Dec 31, 2017	13.00M	-7.38M	-36.23%
Dec 31, 2016	20.38M	14.24M	232.06%
Dec 31, 2015	6.14M	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-
Dec 31, 2012	0	-	-
Dec 31, 2011	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.